APO Research
Talk to an analyst

APO RESEARCH · REPORT

High Mobility Group Protein B1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global High Mobility Group Protein B1 Industry Growth and Trends Forecast to 2032

19 December 202590 pages

Choose your research edition.

Industry ResearchHigh Mobility Group Protein B1 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal High Mobility Group Protein B1 Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal High Mobility Group Protein B1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal High Mobility Group Protein B1 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal High Mobility Group Protein B1 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global High Mobility Group Protein B1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for High Mobility Group Protein B1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for High Mobility Group Protein B1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for High Mobility Group Protein B1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of High Mobility Group Protein B1 include Ribomic Inc, Evec Inc, Dicerna Pharmaceuticals Inc, Cantex Pharmaceuticals Inc and Affibody AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global High Mobility Group Protein B1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The High Mobility Group Protein B1 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global High Mobility Group Protein B1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to High Mobility Group Protein B1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global High Mobility Group Protein B1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

High Mobility Group Protein B1 Market by Company

Ribomic Inc

Evec Inc

Dicerna Pharmaceuticals Inc

Cantex Pharmaceuticals Inc

Affibody AB

High Mobility Group Protein B1 Segment by Type

Dociparstat Sodium

RBM-005

EV-007156

Others

High Mobility Group Protein B1 Segment by Application

Chemotherapy Effects

Cerebral Infarction

Autoimmune Disorders

Others

High Mobility Group Protein B1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High Mobility Group Protein B1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High Mobility Group Protein B1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High Mobility Group Protein B1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of High Mobility Group Protein B1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of High Mobility Group Protein B1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dociparstat Sodium Table 2. Major Company of RBM-005 Table 3. Major Company of EV-007156 Table 4. Major Company of Others Table 5. Global High Mobility Group Protein B1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global High Mobility Group Protein B1 Sales by Type (2021-2026) & (K Units) Table 7. Global High Mobility Group Protein B1 Sales Market Share in Volume by Type (2021-2026) Table 8. Global High Mobility Group Protein B1 Sales by Type (2021-2026) & (US$ Million) Table 9. Global High Mobility Group Protein B1 Sales Market Share in Value by Type (2021-2026) Table 10. Global High Mobility Group Protein B1 Price by Type (2021-2026) & (US$/Unit) Table 11. Global High Mobility Group Protein B1 Sales by Type (2027-2032) & (K Units) Table 12. Global High Mobility Group Protein B1 Sales Market Share in Volume by Type (2027-2032) Table 13. Global High Mobility Group Protein B1 Sales by Type (2027-2032) & (US$ Million) Table 14. Global High Mobility Group Protein B1 Sales Market Share in Value by Type (2027-2032) Table 15. Global High Mobility Group Protein B1 Price by Type (2027-2032) & (US$/Unit) Table 16. North America High Mobility Group Protein B1 Sales by Type (2021-2026) & (K Units) Table 17. North America High Mobility Group Protein B1 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe High Mobility Group Protein B1 Sales by Type (2021-2026) & (K Units) Table 19. Europe High Mobility Group Protein B1 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific High Mobility Group Protein B1 Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific High Mobility Group Protein B1 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America High Mobility Group Protein B1 Sales by Type (2021-2026) & (K Units) Table 23. Latin America High Mobility Group Protein B1 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa High Mobility Group Protein B1 Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa High Mobility Group Protein B1 Sales by Type (2021-2026) & (US$ Million) Table 26. High Mobility Group Protein B1 Industry Trends Table 27. High Mobility Group Protein B1 Industry Drivers Table 28. High Mobility Group Protein B1 Industry Opportunities and Challenges Table 29. High Mobility Group Protein B1 Industry Restraints Table 30. Global High Mobility Group Protein B1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global High Mobility Group Protein B1 Revenue Market Share by Company (2021-2026) Table 32. Global High Mobility Group Protein B1 Sales by Company (2021-2026) & (K Units) Table 33. Global High Mobility Group Protein B1 Sales Share by Company (2021-2026) Table 34. Global High Mobility Group Protein B1 Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global High Mobility Group Protein B1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global High Mobility Group Protein B1 Major Company Production Sites and Headquarters Table 37. Global High Mobility Group Protein B1 Company, Product Type & Application Table 38. Global High Mobility Group Protein B1 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global High Mobility Group Protein B1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global High Mobility Group Protein B1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global High Mobility Group Protein B1 Sales by Region (2021-2026) & (K Units) Table 43. Global High Mobility Group Protein B1 Sales Market Share in Volume by Region (2021-2026) Table 44. Global High Mobility Group Protein B1 Sales by Region (2021-2026) & (US$ Million) Table 45. Global High Mobility Group Protein B1 Sales Market Share in Value by Region (2021-2026) Table 46. Global High Mobility Group Protein B1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global High Mobility Group Protein B1 Sales by Region (2027-2032) & (K Units) Table 48. Global High Mobility Group Protein B1 Sales Market Share in Volume by Region (2027-2032) Table 49. Global High Mobility Group Protein B1 Sales by Region (2027-2032) & (US$ Million) Table 50. Global High Mobility Group Protein B1 Sales Market Share in Value by Region (2027-2032) Table 51. Global High Mobility Group Protein B1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global High Mobility Group Protein B1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global High Mobility Group Protein B1 Sales by Application (2021-2026) & (K Units) Table 54. Global High Mobility Group Protein B1 Sales Market Share in Volume by Application (2021-2026) Table 55. Global High Mobility Group Protein B1 Sales by Application (2021-2026) & (US$ Million) Table 56. Global High Mobility Group Protein B1 Sales Market Share in Value by Application (2021-2026) Table 57. Global High Mobility Group Protein B1 Price by Application (2021-2026) & (US$/Unit) Table 58. Global High Mobility Group Protein B1 Sales by Application (2027-2032) & (K Units) Table 59. Global High Mobility Group Protein B1 Sales Market Share in Volume by Application (2027-2032) Table 60. Global High Mobility Group Protein B1 Sales by Application (2027-2032) & (US$ Million) Table 61. Global High Mobility Group Protein B1 Sales Market Share in Value by Application (2027-2032) Table 62. Global High Mobility Group Protein B1 Price by Application (2027-2032) & (US$/Unit) Table 63. North America High Mobility Group Protein B1 Sales by Application (2021-2026) & (K Units) Table 64. North America High Mobility Group Protein B1 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe High Mobility Group Protein B1 Sales by Application (2021-2026) & (K Units) Table 66. Europe High Mobility Group Protein B1 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific High Mobility Group Protein B1 Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific High Mobility Group Protein B1 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America High Mobility Group Protein B1 Sales by Application (2021-2026) & (K Units) Table 70. Latin America High Mobility Group Protein B1 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa High Mobility Group Protein B1 Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa High Mobility Group Protein B1 Sales by Application (2021-2026) & (US$ Million) Table 73. Ribomic Inc Company Information Table 74. Ribomic Inc Business Overview Table 75. Ribomic Inc High Mobility Group Protein B1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Ribomic Inc High Mobility Group Protein B1 Product Portfolio Table 77. Ribomic Inc Recent Development Table 78. Evec Inc Company Information Table 79. Evec Inc Business Overview Table 80. Evec Inc High Mobility Group Protein B1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Evec Inc High Mobility Group Protein B1 Product Portfolio Table 82. Evec Inc Recent Development Table 83. Dicerna Pharmaceuticals Inc Company Information Table 84. Dicerna Pharmaceuticals Inc Business Overview Table 85. Dicerna Pharmaceuticals Inc High Mobility Group Protein B1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Dicerna Pharmaceuticals Inc High Mobility Group Protein B1 Product Portfolio Table 87. Dicerna Pharmaceuticals Inc Recent Development Table 88. Cantex Pharmaceuticals Inc Company Information Table 89. Cantex Pharmaceuticals Inc Business Overview Table 90. Cantex Pharmaceuticals Inc High Mobility Group Protein B1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Cantex Pharmaceuticals Inc High Mobility Group Protein B1 Product Portfolio Table 92. Cantex Pharmaceuticals Inc Recent Development Table 93. Affibody AB Company Information Table 94. Affibody AB Business Overview Table 95. Affibody AB High Mobility Group Protein B1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Affibody AB High Mobility Group Protein B1 Product Portfolio Table 97. Affibody AB Recent Development Table 98. North America High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America High Mobility Group Protein B1 Sales by Country (2021-2026) & (K Units) Table 100. North America High Mobility Group Protein B1 Sales Market Share by Country (2021-2026) Table 101. North America High Mobility Group Protein B1 Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America High Mobility Group Protein B1 Sales Market Share Forecast by Country (2027-2032) Table 103. North America High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America High Mobility Group Protein B1 Market Size by Country (2021-2026) & (US$ Million) Table 105. North America High Mobility Group Protein B1 Market Share by Country (2021-2026) Table 106. North America High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America High Mobility Group Protein B1 Market Share Forecast by Country (2027-2032) Table 108. Europe High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe High Mobility Group Protein B1 Sales by Country (2021-2026) & (K Units) Table 110. Europe High Mobility Group Protein B1 Sales Market Share by Country (2021-2026) Table 111. Europe High Mobility Group Protein B1 Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe High Mobility Group Protein B1 Sales Market Share Forecast by Country (2027-2032) Table 113. Europe High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe High Mobility Group Protein B1 Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe High Mobility Group Protein B1 Market Share by Country (2021-2026) Table 116. Europe High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe High Mobility Group Protein B1 Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific High Mobility Group Protein B1 Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific High Mobility Group Protein B1 Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific High Mobility Group Protein B1 Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific High Mobility Group Protein B1 Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific High Mobility Group Protein B1 Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific High Mobility Group Protein B1 Market Share by Country (2021-2026) Table 126. Asia-Pacific High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific High Mobility Group Protein B1 Market Share Forecast by Country (2027-2032) Table 128. Latin America High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America High Mobility Group Protein B1 Sales by Country (2021-2026) & (K Units) Table 130. Latin America High Mobility Group Protein B1 Sales Market Share by Country (2021-2026) Table 131. Latin America High Mobility Group Protein B1 Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America High Mobility Group Protein B1 Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America High Mobility Group Protein B1 Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America High Mobility Group Protein B1 Market Share by Country (2021-2026) Table 136. Latin America High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America High Mobility Group Protein B1 Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa High Mobility Group Protein B1 Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa High Mobility Group Protein B1 Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa High Mobility Group Protein B1 Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa High Mobility Group Protein B1 Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa High Mobility Group Protein B1 Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa High Mobility Group Protein B1 Market Share by Country (2021-2026) Table 146. Middle East and Africa High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa High Mobility Group Protein B1 Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. High Mobility Group Protein B1 Distributors List Table 151. High Mobility Group Protein B1 Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. High Mobility Group Protein B1 Image Figure 2. Global High Mobility Group Protein B1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global High Mobility Group Protein B1 Market Size (2021-2032) & (US$ Million) Figure 4. Global High Mobility Group Protein B1 Sales (2021-2032) & (K Units) Figure 5. Dociparstat Sodium Image Figure 6. Global Dociparstat Sodium Sales YoY Growth (2021-2032) & (K Units) Figure 7. RBM-005 Image Figure 8. Global RBM-005 Sales YoY Growth (2021-2032) & (K Units) Figure 9. EV-007156 Image Figure 10. Global EV-007156 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global High Mobility Group Protein B1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global High Mobility Group Protein B1 Market Share by Type 2025 VS 2032 Figure 15. North America High Mobility Group Protein B1 Sales Market Share in Volume by Type in 2025 Figure 16. North America High Mobility Group Protein B1 Sales Market Share in Value by Type in 2025 Figure 17. Europe High Mobility Group Protein B1 Sales Market Share in Volume by Type in 2025 Figure 18. Europe High Mobility Group Protein B1 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific High Mobility Group Protein B1 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific High Mobility Group Protein B1 Sales Market Share in Value by Type in 2025 Figure 21. Latin America High Mobility Group Protein B1 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America High Mobility Group Protein B1 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa High Mobility Group Protein B1 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa High Mobility Group Protein B1 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 High Mobility Group Protein B1 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Chemotherapy Effects Image Figure 28. Global Chemotherapy Effects Sales YoY Growth (2021-2032) & (K Units) Figure 29. Cerebral Infarction Image Figure 30. Global Cerebral Infarction Sales YoY Growth (2021-2032) & (K Units) Figure 31. Autoimmune Disorders Image Figure 32. Global Autoimmune Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global High Mobility Group Protein B1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global High Mobility Group Protein B1 Market Share by Application 2025 VS 2032 Figure 37. North America High Mobility Group Protein B1 Sales Market Share in Volume by Application in 2025 Figure 38. North America High Mobility Group Protein B1 Sales Market Share in Value by Application in 2025 Figure 39. Europe High Mobility Group Protein B1 Sales Market Share in Volume by Application in 2025 Figure 40. Europe High Mobility Group Protein B1 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific High Mobility Group Protein B1 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific High Mobility Group Protein B1 Sales Market Share in Value by Application in 2025 Figure 43. Latin America High Mobility Group Protein B1 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America High Mobility Group Protein B1 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa High Mobility Group Protein B1 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa High Mobility Group Protein B1 Sales Market Share in Value by Application in 2025 Figure 47. North America High Mobility Group Protein B1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America High Mobility Group Protein B1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America High Mobility Group Protein B1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America High Mobility Group Protein B1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe High Mobility Group Protein B1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe High Mobility Group Protein B1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe High Mobility Group Protein B1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe High Mobility Group Protein B1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific High Mobility Group Protein B1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific High Mobility Group Protein B1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific High Mobility Group Protein B1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific High Mobility Group Protein B1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America High Mobility Group Protein B1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America High Mobility Group Protein B1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America High Mobility Group Protein B1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America High Mobility Group Protein B1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa High Mobility Group Protein B1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa High Mobility Group Protein B1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa High Mobility Group Protein B1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa High Mobility Group Protein B1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. High Mobility Group Protein B1 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. High Mobility Group Protein B1 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dociparstat Sodium
  • RBM-005
  • EV-007156
  • Others
Applications
  • Chemotherapy Effects
  • Cerebral Infarction
  • Autoimmune Disorders
  • Others
Companies covered
  • Ribomic Inc
  • Evec Inc
  • Dicerna Pharmaceuticals Inc
  • Cantex Pharmaceuticals Inc
  • Affibody AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global High Mobility Group Protein B1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global High Mobility Group Protein B1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 High Mobility Group Protein B1 Market by Type
  6. 1.3.1 Dociparstat Sodium
  7. 1.3.2 RBM-005
  8. 1.3.3 EV-007156
  9. 1.3.4 Others
  10. 1.4 Global High Mobility Group Protein B1 Market Size by Type
  11. 1.4.1 Global High Mobility Group Protein B1 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global High Mobility Group Protein B1 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global High Mobility Group Protein B1 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America High Mobility Group Protein B1 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe High Mobility Group Protein B1 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific High Mobility Group Protein B1 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America High Mobility Group Protein B1 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa High Mobility Group Protein B1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 High Mobility Group Protein B1 Industry Trends
  2. 2.2 High Mobility Group Protein B1 Industry Drivers
  3. 2.3 High Mobility Group Protein B1 Industry Opportunities and Challenges
  4. 2.4 High Mobility Group Protein B1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by High Mobility Group Protein B1 Revenue (2021-2026)
  2. 3.2 Global Top Players by High Mobility Group Protein B1 Sales (2021-2026)
  3. 3.3 Global Top Players by High Mobility Group Protein B1 Price (2021-2026)
  4. 3.4 Global High Mobility Group Protein B1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global High Mobility Group Protein B1 Major Company Production Sites & Headquarters
  6. 3.6 Global High Mobility Group Protein B1 Company, Product Type & Application
  7. 3.7 Global High Mobility Group Protein B1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global High Mobility Group Protein B1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 High Mobility Group Protein B1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 High Mobility Group Protein B1 Tier 1, Tier 2, and Tier 3
4 High Mobility Group Protein B1 Regional Status and Outlook
  1. 4.1 Global High Mobility Group Protein B1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global High Mobility Group Protein B1 Historic Market Size by Region
  3. 4.2.1 Global High Mobility Group Protein B1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global High Mobility Group Protein B1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global High Mobility Group Protein B1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global High Mobility Group Protein B1 Forecasted Market Size by Region
  7. 4.3.1 Global High Mobility Group Protein B1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global High Mobility Group Protein B1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global High Mobility Group Protein B1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 High Mobility Group Protein B1 by Application
  1. 5.1 High Mobility Group Protein B1 Market by Application
  2. 5.1.1 Chemotherapy Effects
  3. 5.1.2 Cerebral Infarction
  4. 5.1.3 Autoimmune Disorders
  5. 5.1.4 Others
  6. 5.2 Global High Mobility Group Protein B1 Market Size by Application
  7. 5.2.1 Global High Mobility Group Protein B1 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global High Mobility Group Protein B1 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global High Mobility Group Protein B1 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America High Mobility Group Protein B1 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe High Mobility Group Protein B1 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific High Mobility Group Protein B1 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America High Mobility Group Protein B1 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa High Mobility Group Protein B1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ribomic Inc
  2. 6.1.1 Ribomic Inc Company Information
  3. 6.1.2 Ribomic Inc Business Overview
  4. 6.1.3 Ribomic Inc High Mobility Group Protein B1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ribomic Inc High Mobility Group Protein B1 Product Portfolio
  6. 6.1.5 Ribomic Inc Recent Developments
  7. 6.2 Evec Inc
  8. 6.2.1 Evec Inc Company Information
  9. 6.2.2 Evec Inc Business Overview
  10. 6.2.3 Evec Inc High Mobility Group Protein B1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Evec Inc High Mobility Group Protein B1 Product Portfolio
  12. 6.2.5 Evec Inc Recent Developments
  13. 6.3 Dicerna Pharmaceuticals Inc
  14. 6.3.1 Dicerna Pharmaceuticals Inc Company Information
  15. 6.3.2 Dicerna Pharmaceuticals Inc Business Overview
  16. 6.3.3 Dicerna Pharmaceuticals Inc High Mobility Group Protein B1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dicerna Pharmaceuticals Inc High Mobility Group Protein B1 Product Portfolio
  18. 6.3.5 Dicerna Pharmaceuticals Inc Recent Developments
  19. 6.4 Cantex Pharmaceuticals Inc
  20. 6.4.1 Cantex Pharmaceuticals Inc Company Information
  21. 6.4.2 Cantex Pharmaceuticals Inc Business Overview
  22. 6.4.3 Cantex Pharmaceuticals Inc High Mobility Group Protein B1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cantex Pharmaceuticals Inc High Mobility Group Protein B1 Product Portfolio
  24. 6.4.5 Cantex Pharmaceuticals Inc Recent Developments
  25. 6.5 Affibody AB
  26. 6.5.1 Affibody AB Company Information
  27. 6.5.2 Affibody AB Business Overview
  28. 6.5.3 Affibody AB High Mobility Group Protein B1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Affibody AB High Mobility Group Protein B1 Product Portfolio
  30. 6.5.5 Affibody AB Recent Developments
7 North America by Country
  1. 7.1 North America High Mobility Group Protein B1 Sales by Country
  2. 7.1.1 North America High Mobility Group Protein B1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America High Mobility Group Protein B1 Sales by Country (2021-2026)
  4. 7.1.3 North America High Mobility Group Protein B1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America High Mobility Group Protein B1 Market Size by Country
  6. 7.2.1 North America High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America High Mobility Group Protein B1 Market Size by Country (2021-2026)
  8. 7.2.3 North America High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe High Mobility Group Protein B1 Sales by Country
  2. 8.1.1 Europe High Mobility Group Protein B1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe High Mobility Group Protein B1 Sales by Country (2021-2026)
  4. 8.1.3 Europe High Mobility Group Protein B1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe High Mobility Group Protein B1 Market Size by Country
  6. 8.2.1 Europe High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe High Mobility Group Protein B1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific High Mobility Group Protein B1 Sales by Country
  2. 9.1.1 Asia-Pacific High Mobility Group Protein B1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific High Mobility Group Protein B1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific High Mobility Group Protein B1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific High Mobility Group Protein B1 Market Size by Country
  6. 9.2.1 Asia-Pacific High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific High Mobility Group Protein B1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America High Mobility Group Protein B1 Sales by Country
  2. 10.1.1 South America High Mobility Group Protein B1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America High Mobility Group Protein B1 Sales by Country (2021-2026)
  4. 10.1.3 South America High Mobility Group Protein B1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America High Mobility Group Protein B1 Market Size by Country
  6. 10.2.1 South America High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America High Mobility Group Protein B1 Market Size by Country (2021-2026)
  8. 10.2.3 South America High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa High Mobility Group Protein B1 Sales by Country
  2. 11.1.1 Middle East and Africa High Mobility Group Protein B1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa High Mobility Group Protein B1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa High Mobility Group Protein B1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa High Mobility Group Protein B1 Market Size by Country
  6. 11.2.1 Middle East and Africa High Mobility Group Protein B1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa High Mobility Group Protein B1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa High Mobility Group Protein B1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 High Mobility Group Protein B1 Value Chain Analysis
  2. 12.1.1 High Mobility Group Protein B1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 High Mobility Group Protein B1 Production Mode & Process
  7. 12.2 High Mobility Group Protein B1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 High Mobility Group Protein B1 Distributors
  10. 12.2.3 High Mobility Group Protein B1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst